首页 英文研究报告文章正文

【英文】美国智库ITIF报告:抓住癌早期筛查的变革机遇(45页)

英文研究报告 2021年04月28日 06:49 1 管理员

This report begins by examining the social and economic costs cancer inflicts. It discusses the  importance of early cancer detection and moves on to an exploration of how MCED technologies  work, evidence of their effectiveness to date, the benefits they are capable of providing, and why  it’s important the United States remain the global leader in this field. It then analyzes the  regulatory and coverage environment before concluding by providing recommendations for how  policymakers can enact policies enabling this transformative technology to flourish, including  by passing legislation creating a pathway to ensure timely Medicare coverage of MCED  screening exams. 

THE INDIVIDUAL, SOCIAL, AND ECONOMIC COSTS OF CANCER Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of  abnormal cells.1 It remains one of America’s, and global societies’, greatest health challenges. Cancer is responsible for almost one in six deaths globally.2 The global cancer burden is  expected to surpass 20 million new yearly cases by 2025.3 Cancer is the second-most common  cause of death in the United States, exceeded only by heart disease, although cancer is  expected to become the leading cause of American fatalities by 2030. 

Likewise, among  adults ages 35 to 70, while cardiovascular disease remains the leading cause of mortality  globally, “mortality from cancer will probably become the leading cause of death” in the near  future.4 Experts predict the year 2021 will see 1.9 million new cancer cases diagnosed in the  United States, with over 600,000 Americans expected to perish from the disease, which  translates to about 1,650 deaths per day.

【英文】美国智库ITIF报告:抓住癌早期筛查的变革机遇(45页)

文件下载
资源名称:【英文】美国智库ITIF报告:抓住癌早期筛查的变革机遇(45页)


标签: ENGLISH REPORTS

并购家 站点地图   关于我们   意见反馈   免责声明 京ICP备12009579号-9